Clik here to view.
AVITA Medical Announces Presentation of RECELL® Device Effectiveness and...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that results from two U.S. pivotal clinical trials demonstrating the effectiveness and clinical...
View ArticleClik here to view.
Gynesonics Receives FDA Clearance to Market Sonata® System
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has received 510(k)...
View ArticleClik here to view.
美国政府向22nd Century订购360万支SPECTRUM®研究用香烟
纽约州克拉伦斯 (美国商业资讯) — 22nd Century Group, Inc. (NYSE American: XXII)是一家专注于烟草减害和极低尼古丁烟草的植物技术公司，公司今天宣布，国立药品滥用研究院(NIDA)、美国食品药品管理局(FDA)以及公共卫生研究人员新近求购大量22nd Century的专利SPECTRUM®研究用香烟。经与NIDA、FDA及各方协调，RTI...
View ArticleClik here to view.
Global Virus Network Adds Singapore Consortium as Newest Center of Excellence
BALTIMORE & SINGAPORE The Global Virus Network (GVN) and the GVN-Singapore Center of Excellence, comprised of 7 virology research intuitions led by Duke-NUS Medical School, announced today the...
View ArticleClik here to view.
Pfizer and Astellas Amend Clinical Research Protocols for Two Phase 3 Trials...
NEW YORK & TOKYO Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced amendments to the protocols for two...
View ArticleClik here to view.
AVITA Medical Announces Commencement of Manufacturing of RECELL® Device in...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced the successful completion of multiple production runs for the RECELL Device® within its newly...
View ArticleClik here to view.
22ndセンチュリー、米国政府研究用のスペクトラム紙巻きたばこ360万本を受注
米ニューヨーク州クラレンス （ビジネスワイヤ） — タバコの有害性低減と超低ニコチンタバコに傾注する植物バイオテクノロジー企業の22ndセンチュリー・グループ（NYSE American:...
View ArticleClik here to view.
ＰＨＣホールディングス株式会社：中小規模病院向けにWeb型電子カルテシステム「Medicom-CK」を販売開始―院内連携を強化し、チーム医療をサポート
東京 （ビジネスワイヤ） – ＰＨＣホールディングス株式会社（本社：東京都港区）の１００％子会社である、ＰＨＣ株式会社（以下「ＰＨＣ」）は、このたび、中小規模病院向け電子カルテシステム「Medicom-CK」を発売しましたので、お知らせします。...
View ArticleClik here to view.
和铂医药完成B轮融资8500万美元 加速创新产品线研发
中国上海、荷兰鹿特丹、美国马萨诸塞州剑桥 和铂医药今天宣布成功完成B轮融资8500万美元，以加速公司创新产品线的成长，尤其是公司临床阶段项目及临床前项目的快速推进。本轮融资由新加坡政府投资公司GIC领投，国寿大健康基金、祥峰投资参与，A轮投资机构尚珹资本与君联资本跟投。...
View ArticleClik here to view.
Harbour BioMed Raises $85 Million in Series B Financing to Accelerate Its...
SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass. Harbour BioMed announced today that it has completed a Series B round financing of $85 million to accelerate the growth of its...
View ArticleClik here to view.
New Study Evaluates the Ability of Masimo ORi™ to Reflect Oxygenation During...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today the findings of a study recently published in Anesthesia & Analgesia in which researchers at the University of Groningen, the...
View ArticleClik here to view.
Strategia Holdings Announces Strategic Partnership Alliance with JS InnoPharm...
BOSTON Strategia Holdings, LLC. announced a strategic partnership alliance with JS InnoPharm (Shanghai), Ltd. to facilitate global drug development. Through this partnership, both companies will...
View ArticleClik here to view.
新近研究评估Masimo ORi™反映中度高氧期间氧合状况的功能
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了《麻醉与镇痛》杂志最近发表的一项研究成果，该研究中，荷兰格罗宁根大学与比利时根特大学的研究人员调查了 Masimo...
View ArticleClik here to view.
Patient-Driven Gene Therapy Company ReflectionBio Receives Orphan Drug...
HONG KONG & NEW YORK Reflection Biotechnologies Limited (“ReflectionBio”), a gene therapy company committed to the research and development of life-changing treatments for rare diseases, today...
View ArticleClik here to view.
Geneious Desktop Software to Be Renamed to Geneious Prime
AUCKLAND, New Zealand Biomatters today announces that Geneious, its world-leading desktop suite of molecular biology and sequence analysis tools, will be renamed to Geneious Prime later this year....
View ArticleClik here to view.
NZMP SureStart™入围NutraIngredients-Asia决赛奖项
新西兰奥克兰 (美国商业资讯) — 恒天然(Fonterra)NZMP SureStart™婴幼儿品类乳脂原料“MFGM Lipid 100”已入围NutraIngredients-Asia婴儿营养类决赛奖项，此颁奖盛典即将在新加坡举办。恒天然的消费者品牌Anmum™率先应用该创新原料在孕妇及婴幼儿产品中，名为Anmum™ Nuelipid™推向市场。...
View ArticleClik here to view.
NZMP SureStart™ Shortlisted as a Finalist in the NutraIngredients-Asia Awards
AUCKLAND, New Zealand Fonterra’s NZMP SureStart™ milk lipid ingredient ‘MFGM Lipid 100’ has been selected as a finalist in the NutraIngredients-Asia awards for Infant Nutrition in Singapore....
View ArticleClik here to view.
中程度の酸素過剰状態における酸素化を反映するMasimo ORi™の性能を評価した新研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、Anesthesia & Analgesia誌に最近掲載された研究についての知見を発表しました。オランダのフローニンゲン大学とベルギーのゲント大学の研究者らが実施した本研究では、中程度の過酸素の範囲における酸素化（100～200...
View ArticleClik here to view.
Celltrion Finalizes Clinical Trials for Remsima SC, Planning to File a...
INCHEON, South Korea Celltrion, Inc. (KRX:068270) today announced that the company has completed Phase 3 clinical trial for ‘Remsima SC’, the subcutaneous (SC) version of Remsima®, the autoimmune...
View ArticleClik here to view.
レスメドのAstral生命維持人工呼吸器が米国でAutoEPAPを搭載
サンディエゴ （ビジネスワイヤ） — クラウド接続型呼吸ケアデバイスの世界的リーダー企業であるレスメド（NYSE: RMD）（ASX: RMD）は本日、米国患者にとっての治療選択肢として大きな需要があるiVAPSでのAutoEPAPオプションを含め、当社のAstral生命維持人工呼吸器の重要なアップグレードを発表しました。...
View Article